Host Daniel Culver, DO, is joined by Cleveland Clinic pulmonologists Rachel Scheraga, MD, and Vickram Tejwani, MD, for a recap of the 2026 American Thoracic Society Conference (ATS). They discuss key scientific and clinical highlights, including support for early-career investigators, ATS NOW, advances in lung microenvironment research, emerging airway disease therapies targeting IL-33, and promising pulmonary fibrosis data. The conversation also explores how collaboration, technology, and team-based science are reshaping respiratory research and what the future of major medical meetings may look like.
